Fermenta Biotech Ltd.

FERMENTA NSE Healthcare Pharmaceuticals
₹474.65
-1.86%
Delayed · cached 15 min

Fair value analysis

FERMENTA
Fermenta Biotech Ltd.
Healthcare›Pharmaceuticals
₹483.65
Close used for this calculation
₹535.62Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
52/100
Profitability15/25
Returns12/25
Balance Sheet19/25
Efficiency6/25
Growth8/25
Good
Quality radar
52Prof.15/25Ret.12/25Eff.6/25B.Sht19/25Growth8/25

Consensus fair value

₹535.62
Near FV
▲ +10.7% against the close used
Model range ₹231.71 – ₹870.72
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹231.71Fair value₹535.62Bull₹870.72
FairClose
52-week traded range
52W low ₹454.2052W high ₹520.65

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

Fermenta Biotech Ltd. closed at ₹483.65, 9.7% below the consensus fair value of ₹535.62 drawn from 9 valuation models.

Financial DNA score 52/100 — Good. P/E of 25.5x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹432.93
-10.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹242.59
-49.8%
√(22.5 × EPS × BVPS)
EPS=24.39, BVPS=107.24 · outside Graham range (P/E 25.5, P/B 4.5) — asset-light, treat as a rough floor
Graham Formula
₹622.82
+28.8%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=9.5%, FD=7%
P/E Fair Value
₹870.72
+80.0%
EPS × 35.7x (sector P/E)
EPS=24.39, Sector P/E=35.7x
Peter Lynch (PEG)
₹231.71
-52.1%
EPS × Growth% (PEG = 1 is fair)
EPS=24.39, g=9.5%
EV/EBITDA
₹588.98
+21.8%
(EBITDA × 14.8x − Net Debt) ÷ Shares
EBITDA=1.23B
Book Value (P/B)
₹278.82
-42.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=107.24, ROE=16.4%, g=6%, r=10%
Reverse DCF
₹483.65
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7% | Historical: 9.5%
Margin of Safety
₹406.70
-15.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=542.27, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.